Report outlines UK strategy for regenerative medicines
This article was originally published in SRA
Executive Summary
A new report has revealed how the UK government plans to ensure that the regulatory framework for regenerative medicines is "facilitating" and is supported by a strong intellectual property regime and appropriate standards"1,2.